PATENT CLAIM ANALYSIS

Application Number: 15867829
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "003800"]

Abstract:
The subject invention pertains to methods of treating HIV-1 infected subject comprising the administration of growth hormone to a subject infected by HIV-1. The subject may be undergoing co-administration of anti-retroviral therapies (ARTs), may be untreated with anti-retroviral drugs (ARDs) or may be in a period of time where no ART is being administered. Growth hormone may be administered at a fixed dosage for a set period of time or may be administered at a first dosage for a first period of time that may then be increased or decreased to a second dosage for a second period of time.

Claim (Index 16):
The method according to  claim 6 , wherein said subject is in an anti-retroviral therapy (ART) free period.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15114296', '13794467', '15429311', '11877395', '10969463']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7578703662503699
- 35 USC 102 Novelty (BERT): 0.5173225706872431
- Combined Prediction Score: 0.7338155866940572
- Mean Citation Score: 195.07115
- Max Citation Score: 212.00377000000003
- Similarity Product: 109.55068158001842

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test